Status:
COMPLETED
Hypertension, Antihypertensive Medication Use, and Risk of Psoriasis
Lead Sponsor:
Xijing Hospital
Conditions:
Psoriasis
Eligibility:
All Genders
18-80 years
Brief Summary
The influences of hypertension and antihypertensive medication on psoriasis have been long discussed. Given the limited and inconsistent evidence available, there is a need to further explore and clar...
Detailed Description
The investigators conducted a retrospective cohort study of psoriasis patients (≥18 years old) admitted as inpatients of Xijing hospital. Prior to the commencement of the survey, the investigators und...
Eligibility Criteria
Inclusion
- Age ≥18 years;
- Clear diagnosis of psoriasis
Exclusion
- Age \<18;
- Hypertension caused by conditions such as primary hypertension, hyperthyroidism, chronic renal insufficiency, or Cushing's syndrome, which are severe endocrine system diseases;
- Patients with autoimmune diseases, severe cardiovascular, hepatic, renal, or other major organ disorders, as well as blood disorders and endocrine system diseases.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
9294 Patients enrolled
Trial Details
Trial ID
NCT06075394
Start Date
November 1 2021
End Date
October 1 2023
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Derpartment of Xijing Hospital
Xi'an, Shaanxi, China, 710032